Beacon Pointe Advisors’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,425
| Closed | -$496K | – | 1231 |
|
|
2024
Q3 | $496K | Sell |
7,425
-2,167
| -23% | -$145K | 0.01% | 851 |
|
|
2024
Q2 | $1.14M | Sell |
9,592
-632
| -6% | -$75.1K | 0.01% | 602 |
|
|
2024
Q1 | $1.09M | Sell |
10,224
-1,337
| -12% | -$142K | 0.01% | 662 |
|
|
2023
Q4 | $1.15M | Sell |
11,561
-2,295
| -17% | -$228K | 0.01% | 618 |
|
|
2023
Q3 | $1.43M | Buy |
13,856
+1,864
| +16% | +$193K | 0.02% | 532 |
|
|
2023
Q2 | $1.46M | Buy |
11,992
+6,458
| +117% | +$785K | 0.02% | 432 |
|
|
2023
Q1 | $850K | Buy |
5,534
+3,248
| +142% | +$499K | 0.01% | 586 |
|
|
2022
Q4 | $411K | Sell |
2,286
-109
| -5% | -$19.6K | 0.01% | 756 |
|
|
2022
Q3 | $282K | Sell |
2,395
-140
| -6% | -$16.5K | 0.01% | 819 |
|
|
2022
Q2 | $365K | Sell |
2,535
-1,153
| -31% | -$166K | 0.01% | 759 |
|
|
2022
Q1 | $635K | Sell |
3,688
-701
| -16% | -$121K | 0.01% | 740 |
|
|
2021
Q4 | $1.12M | Sell |
4,389
-140
| -3% | -$35.6K | 0.03% | 362 |
|
|
2021
Q3 | $1.74M | Sell |
4,529
-2,345
| -34% | -$902K | 0.04% | 299 |
|
|
2021
Q2 | $1.62M | Buy |
6,874
+4,288
| +166% | +$1.01M | 0.06% | 253 |
|
|
2021
Q1 | $338K | Sell |
2,586
-1,130
| -30% | -$148K | 0.02% | 362 |
|
|
2020
Q4 | $389K | Buy |
3,716
+637
| +21% | +$66.7K | 0.03% | 320 |
|
|
2020
Q3 | $218K | Sell |
3,079
-3,478
| -53% | -$246K | 0.02% | 359 |
|
|
2020
Q2 | $421K | Buy |
+6,557
| New | +$421K | 0.04% | 258 |
|